The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease

Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug delivery system. This article reviews the clinical efficacy and tolerability of Rotigotine transdermal patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Marina Romanovna Nodel
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: IMA-PRESS LLC 2013-11-01
Cyfres:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Pynciau:
parkinson's disease
levodopa
dopamine receptor agonists
rotigotine
transdermal patch
therapy
compliance
fluctuations
dyskinesis
Mynediad Ar-lein:https://nnp.ima-press.net/nnp/article/view/257
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg